Publications by authors named "K Cypryk"
Assessment of Changes in the Expression of Genes Involved in Insulin Signaling and Glucose Transport in Leukocytes of Women with Gestational Diabetes During Pregnancy and in the Postpartum Period.
Int J Mol Sci
December 2024
Not much is currently known about disturbances in insulin signaling and glucose transport in leukocytes of women with gestational diabetes mellitus (GDM) during and after pregnancy. In this study, the expression of insulin signaling (, , and and glucose transporter (, and )-related genes in the leukocytes of 92 pregnant women was assayed using quantitative RT-PCR. The cohort consisted of 44 women without GDM (NGT group) and 48 with GDM (GDM group) at 24-28 weeks of gestation.
View Article and Find Full Text PDFArticle Synopsis
- This review focuses on two methods for assessing microvascular function using the Flow-Mediated Skin Fluorescence (FMSF) technique, highlighting the significance of microcirculatory oscillations.
- The first method analyzes parameters like flowmotion, vasomotion, and the normoxia oscillatory index to identify issues related to exercise, post-COVID syndrome, psychological stress, and erectile dysfunction.
- The second method evaluates hypoxia sensitivity to understand microvascular complications in diabetes, such as kidney disease and foot ulcers, suggesting the potential for broad medical applications of the FMSF technique.
Introduction: Diabetic cardiomyopathy in young patients with type 1 diabetes (T1D) usually presents as asymptomatic diastolic heart dysfunction with left ventricle (LV) remodeling. Its prevalence seems to be underestimated. One of the factors seemingly influencing LV remodeling is a metabolic-associated steatotic liver disease (MASLD), which was extensively investigated in patients with type 2 diabetes but not with T1D.
View Article and Find Full Text PDFUnlabelled: We aimed to evaluate glycaemic control in patients with type 1 diabetes during the first three months of use of the flash glucose monitoring (FGM) system.
Methods: We conducted a study of a cohort of 81 people with type 1 diabetes mellitus who used the FreeStyle Libre 2 (FSL2) sensor continuously for 3 months. Patients had not used a CGM before.